Traynor Capital Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $298K | Sell |
|
|||||
|
2021
Q4 | $476K | Buy |
|
|||||
|
2021
Q3 | $476K | Buy |
|
|||||
|
2021
Q2 | $432K | Buy |
|
|||||
|
2021
Q1 | $344K | Buy |
|
|||||
|
2020
Q4 | $306K | Sell |
|
|||||
|
2020
Q3 | $295K | Buy |
|
|||||
|
2020
Q2 | $294K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $276K | Sell |
|
|||||
|
2018
Q2 | $232K | Sell |
|
|||||
|
2018
Q1 | $235K | Buy |
|
|||||
|
2017
Q4 | $235K | Buy |
|
|||||
|
2017
Q3 | $223K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $268K | Sell |
|
|||||
|
2016
Q2 | $320K | Sell |
|
|||||
|
2016
Q1 | $453K | Buy |
|
|||||
|
2015
Q4 | $405K | Sell |
|
|||||
|
2015
Q3 | $479K | Buy |
|
|||||
|
2015
Q2 | $604K | Buy |
|
|||||
|
2015
Q1 | $478K | Buy |
|
|||||
|
2014
Q4 | $242K | Buy |
|